Why on earth would anyone subscribe to this? 25 cents in 18 months is ridiculous. I cannot see any progress on any of their flimsy projects in the next 10 years, plus. My opinion only. No doubt Eyeover sees it differently, and will climb in!
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor